Cti Biopharm Corp (CTIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 1,343 | 1,411 | 32,884 | 362 | 306 |
| Cost of Goods | 202 | 145 | 33 | 13 | 36 |
| Gross Profit | 1,141 | 1,266 | 32,851 | 349 | 270 |
| Operating Expenses | 28,011 | 29,074 | 22,551 | 15,847 | 18,158 |
| Operating Income | -26,668 | -27,663 | 10,333 | -15,485 | -17,852 |
| Interest Expense | 467 | 464 | 346 | 316 | 316 |
| Other Income | -344 | -1,069 | -17 | 117 | -52 |
| Pre-tax Income | -27,479 | -29,196 | 9,970 | -15,684 | -18,220 |
| Net Income Continuous | -27,479 | -29,196 | 9,970 | -15,684 | -18,220 |
| Minority Interests | -80 | -194 | -226 | -140 | -209 |
| Net Income | $-27,399 | $-29,002 | $10,196 | $-15,544 | $-18,011 |
| EPS Basic Total Ops | -1.90 | -2.00 | 1.20 | -2.00 | -1.70 |
| EPS Basic Continuous Ops | -1.90 | -2.05 | 1.13 | -1.41 | -1.69 |
| EPS Diluted Total Ops | -1.90 | -2.00 | 1.20 | -2.00 | -1.70 |
| EPS Diluted Continuous Ops | -1.90 | -2.05 | 1.13 | -1.41 | -1.69 |
| EBITDA(a) | $-26,412 | $-27,303 | $10,696 | $-15,095 | $-17,446 |